Media Releases

2018

29/05/2018

Proteomics International signs deal to launch PromarkerD test for diabetic kidney disease in USA

19/04/2018

Europe PromarkerD patent granted for diabetic kidney disease

06/04/2018

Conversion of 90% of Proteomics Options raises of $3m

07/03/2018

Proteomics launches PromarkerD

02/02/2018

Strategic alliance and investment in CPR Pharma Services

29/01/2018

PromarkerD diabetic kidney disease patent granted in Japan

2017

14/12/2017

Proteomics and Dimerix partner to improve the treatment of kidney disease

04/12/2017

Proteomics joins major health study to target lung disease

27/11/2017

PromarkerD predictive diagnostic test to launch in Q1 2018

22/11/2017

Proteomics strengthens Board and Business Development team

14/11/2017

Proteomics awards Inaugural STEM scholarship to Perth teenager

26/10/2017

Proteomics partnered consortium to receive $2 million

10/10/2017

Proteomics receives R&D tax incentive

06/09/2017

PromarkerD predictive test results published – Diabetes Care

16/08/2017

US PromarkerD patent expanded to all kidney disease

1
2
3
4
5
6
7
8